<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><journal-title>PLoS Genetics</journal-title><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PLGE-RA-0892R2</article-id><article-id pub-id-type="doi">10.1371/journal.pgen.1000286</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry</subject><subject>Genetics and Genomics</subject><subject>Infectious Diseases/Neglected Tropical Diseases</subject><subject>Molecular Biology</subject><subject>Public Health and Epidemiology/Infectious Diseases</subject><subject>Public Health and Epidemiology/Screening</subject></subj-group></article-categories><title-group><article-title>Field-Caught Permethrin-Resistant <italic>Anopheles gambiae</italic> Overexpress CYP6P3, a P450 That Metabolises Pyrethroids</article-title><alt-title alt-title-type="running-head">Pyrethroid Metabolism in <italic>Anopheles gambiae</italic></alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>M&#x000fc;ller</surname><given-names>Pie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Warr</surname><given-names>Emma</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn1"><sup>&#x000a4;</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Stevenson</surname><given-names>Bradley J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pignatelli</surname><given-names>Patricia M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Morgan</surname><given-names>John C.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Steven</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yawson</surname><given-names>Alexander E.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mitchell</surname><given-names>Sara N.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ranson</surname><given-names>Hilary</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hemingway</surname><given-names>Janet</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Paine</surname><given-names>Mark J. I.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Donnelly</surname><given-names>Martin J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Vector Group, Liverpool School of Tropical Medicine, Liverpool, United Kingdom</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Biotechnology and Nuclear Agricultural Research Institute, Ghana Atomic Energy Commission, Kwabenya, Accra, Ghana</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Stern</surname><given-names>David L.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Princeton University, Howard Hughes Medical Institute, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>pie.muller@liv.ac.uk</email></corresp><fn id="fn1" fn-type="current-aff"><label>&#x000a4;</label><p>Current address: Centre for Applied Entomology and Parasitology, School of Life Sciences, Keele University, Staffordshire, United Kingdom</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: PM EW BJS PMP MJIP MJD. Performed the experiments: PM EW BJS PMP JCM AS SNM MJD. Analyzed the data: PM EW BJS. Contributed reagents/materials/analysis tools: AEY. Wrote the paper: PM EW BJS HR JH MJIP MJD. Oversaw experimental design and analysis: HR MJIP MJD.</p></fn></author-notes><pub-date pub-type="collection"><month>11</month><year>2008</year></pub-date><!-- Fake ppub added to accomodate plos workflow change from 03/2008 --><pub-date pub-type="ppub"><month>11</month><year>2008</year></pub-date><pub-date pub-type="epub"><day>28</day><month>11</month><year>2008</year></pub-date><volume>4</volume><issue>11</issue><elocation-id>e1000286</elocation-id><history><date date-type="received"><day>19</day><month>7</month><year>2008</year></date><date date-type="accepted"><day>29</day><month>10</month><year>2008</year></date></history><copyright-statement>M&#x000fc;ller et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2008</copyright-year><abstract><p>Insects exposed to pesticides undergo strong natural selection and have developed various adaptive mechanisms to survive. Resistance to pyrethroid insecticides in the malaria vector <italic>Anopheles gambiae</italic> is receiving increasing attention because it threatens the sustainability of malaria vector control programs in sub-Saharan Africa. An understanding of the molecular mechanisms conferring pyrethroid resistance gives insight into the processes of evolution of adaptive traits and facilitates the development of simple monitoring tools and novel strategies to restore the efficacy of insecticides. For this purpose, it is essential to understand which mechanisms are important in wild mosquitoes. Here, our aim was to identify enzymes that may be important in metabolic resistance to pyrethroids by measuring gene expression for over 250 genes potentially involved in metabolic resistance in phenotyped individuals from a highly resistant, wild <italic>A. gambiae</italic> population from Ghana. A cytochrome P450, <italic>CYP6P3</italic>, was significantly overexpressed in the survivors, and we show that the translated enzyme metabolises both alpha-cyano and non&#x02013;alpha-cyano pyrethroids. This is the first study to demonstrate the capacity of a P450 identified in wild <italic>A. gambiae</italic> to metabolise insecticides. The findings add to the understanding of the genetic basis of insecticide resistance in wild mosquito populations.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>Malaria, a disease spread by anopheline mosquitoes, is a global health problem with an enormous economic and social impact. Pyrethroid insecticides are critical in reducing malaria transmission, and resistance to these insecticides threatens current control efforts. With a limited number of public health insecticides available for the foreseeable future, it is vital to monitor levels of resistance to facilitate decisions on when new strategies should be implemented before control fails. For monitoring, simple molecular assays are highly desirable, because they can detect resistance at very low frequencies and should identify the presence of single recessive alleles well before bioassays. An understanding of the mechanisms conferring resistance facilitates the development of such tools and may also lead to novel strategies to restore the efficacy of the insecticide, or the development of new compounds. We set out to identify enzymes that may confer metabolic pyrethroid resistance by comparing levels of messenger RNA between insecticide-selected versus unselected mosquitoes. We caught members of the major malaria vector, <italic>A. gambiae s.s.</italic> from a highly pyrethroid resistant field population. We found increased transcript levels for a cytochrome P450, <italic>CYP6P3</italic>, and demonstrate that it encodes for an enzyme that metabolises pyrethroids.</p></abstract><counts><page-count count="10"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Insecticide resistance in disease vectors is one of the greatest challenges to the reduction of the burden caused by vector-borne diseases in developing countries. Beyond their public health importance insect vectors are increasingly regarded as model organisms with insecticide resistance serving as an excellent example of natural selection <xref ref-type="bibr" rid="pgen.1000286-Pinto1">&#x0005b;1&#x0005d;</xref>. In many parts of Africa, the malaria vector, <italic>Anopheles gambiae</italic> shows high levels of resistance to pyrethroid insecticides which are the mainstay of vector control <xref ref-type="bibr" rid="pgen.1000286-WHO1">&#x0005b;2&#x0005d;</xref> and there is evidence that this resistance may reduce the efficacy of treated bednets and indoor residual spraying with pyrethroids <xref ref-type="bibr" rid="pgen.1000286-NGuessan1">&#x0005b;3&#x0005d;</xref>. Moreover, some pyrethroid resistance mechanisms that confer cross-resistance to DDT are geographically widespread <xref ref-type="bibr" rid="pgen.1000286-Santolamazza1">&#x0005b;4&#x0005d;</xref>. The stark reality facing control program managers is that there is resistance to the primary compounds used for vector control and that no new active ingredients have become commercially available for public health use in the last 20 years. Studies of resistance mechanisms are key to both understanding the evolution of resistance and to minimising its impact on disease control.</p><p>At the biochemical level, two classes of mechanism are predominantly associated with insecticide resistance; changes in the sensitivity of insecticide targets in the nervous system and metabolism of insecticides before they reach their target <xref ref-type="bibr" rid="pgen.1000286-Hemingway1">&#x0005b;5&#x0005d;</xref>. In <italic>A. gambiae</italic>, target-site resistance to DDT and pyrethroids is associated with a knock-down resistance (<italic>kdr</italic>) mutation in the voltage-gated sodium channel gene. The <italic>kdr</italic> alleles are characterised by two point mutations resulting in either a L1014F <xref ref-type="bibr" rid="pgen.1000286-MartinezTorres1">&#x0005b;6&#x0005d;</xref> or L1014S <xref ref-type="bibr" rid="pgen.1000286-Ranson1">&#x0005b;7&#x0005d;</xref> substitution. The mutations may be present alone or in combination and have arisen from multiple mutation events <xref ref-type="bibr" rid="pgen.1000286-Pinto1">&#x0005b;1&#x0005d;</xref>.</p><p>While insecticide resistance associated with <italic>kdr</italic> is well studied at the physiological, behavioural and population level, much less is known about the enzymes associated with metabolic resistance. One route of metabolic resistance is through up-regulation of detoxification enzymes. Overexpression of enzymes related to insecticide resistance is generally assumed to be associated with cytochrome P450-dependent monooxygenases (P450), carboxylesterases (COE), and glutathione-S transferases (GST). Among these three families, evidence suggests that P450s commonly play a primary role in pyrethroid resistance (for reviews see <xref ref-type="bibr" rid="pgen.1000286-Feyereisen1">&#x0005b;8&#x0005d;</xref> and <xref ref-type="bibr" rid="pgen.1000286-Li1">&#x0005b;9&#x0005d;</xref>). To date, out of 111 putative <italic>A. gambiae s.s.</italic> P450s <xref ref-type="bibr" rid="pgen.1000286-Ranson2">&#x0005b;10&#x0005d;</xref> four have been observed to be overexpressed in adult mosquitoes from colonies characterised as pyrethroid resistant, namely <italic>CYP6Z1</italic>, <italic>CYP6Z2</italic>, <italic>CYP6M2</italic> and <italic>CYP325A3</italic><xref ref-type="bibr" rid="pgen.1000286-David1">&#x0005b;11&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000286-Nikou1">&#x0005b;13&#x0005d;</xref>. Although the up-regulation of these P450s was associated with resistance, their potential to metabolise pyrethroids remains unclear. While Chiu <italic>et al.</italic><xref ref-type="bibr" rid="pgen.1000286-Chiu1">&#x0005b;14&#x0005d;</xref> demonstrated that CYP6Z1 metabolises DDT, to date only CYP6Z2 interacts with pyrethroids. McLaughlin <italic>et al.</italic><xref ref-type="bibr" rid="pgen.1000286-McLaughlin1">&#x0005b;15&#x0005d;</xref> found that CYP6Z2 binds to two pyrethroids, permethrin and cypermethrin. Their data, however, also suggested that the pyrethroids were not metabolised by this P450 highlighting the importance of functionally characterising putative candidates involved in pyrethroid metabolism. These earlier studies have potential confounding effects of colonisation including genetic drift and physiological adaptations to the artificial laboratory environment. The study of immune response in natural mosquito populations has highlighted that mechanisms found in laboratory colonised material may be less relevant in nature <xref ref-type="bibr" rid="pgen.1000286-Riehle1">&#x0005b;16&#x0005d;</xref>.</p><p>While genetic markers for target site insensitivity are available <xref ref-type="bibr" rid="pgen.1000286-MartinezTorres1">&#x0005b;6&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000286-Ranson1">&#x0005b;7&#x0005d;</xref> and widely used, we lack simple screening methods for alleles associated with up-regulation of detoxification enzymes. As a result, the role of metabolic resistance in reducing the efficacy of malaria vector control is unknown. The current study was carried out as part of the Innovative Vector Control Consortium (IVCC) to develop a tool to monitor mosquito field populations for resistance alleles <xref ref-type="bibr" rid="pgen.1000286-Hemingway2">&#x0005b;17&#x0005d;</xref>. We set out to identify enzymes that metabolise pyrethroid insecticides by selecting field-caught mosquitoes against the lethal time to kill 50&#x00025; of the mosquito population (LT<sub>50</sub>). Genes potentially associated with detoxification of xenobiotics were screened for differential gene expression between survivors and unexposed mosquitoes using the <italic>A. gambiae detox chip</italic><xref ref-type="bibr" rid="pgen.1000286-David1">&#x0005b;11&#x0005d;</xref>. We then expressed the most promising candidate in <italic>Escherichia coli</italic> to examine its pyrethroid metabolising potential.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Mosquito Collections</title><p>Mosquito collections were carried out in the village of Dodowa, Ghana (05&#x000b0;52.67&#x02032;N, 000&#x000b0;06.36&#x02032;W) between October and November 2006. A detailed description of the field site can be found in Yawson <italic>et al.</italic><xref ref-type="bibr" rid="pgen.1000286-Yawson1">&#x0005b;18&#x0005d;</xref>. Mosquitoes morphologically identified as members of the <italic>A. gambiae</italic> species complex <xref ref-type="bibr" rid="pgen.1000286-Gillies1">&#x0005b;19&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000286-Gillies2">&#x0005b;20&#x0005d;</xref> were sampled from natural breeding sites and raised to adults in an insectary located in Dodowa. Larvae were given ground TetraMin fish food and adults were provided with 10&#x00025; sugar solution. Newly emerged adults were separated into females and males and kept as cohorts of same age. All bioassays and selections were performed on the third day post-eclosion.</p><p>In addition to the larval collections blood-fed females were caught using aspirators inside houses and family lines reared as described in M&#x000fc;ller <italic>et al.</italic><xref ref-type="bibr" rid="pgen.1000286-Mller2">&#x0005b;21&#x0005d;</xref>. These family lines were used to compare constitutive versus induced gene expression (see below).</p></sec><sec id="s2b"><title>Selection Experiment</title><p>Before selecting mosquitoes against permethrin we determined the lethal time (LT) of 0.75&#x00025; permethrin treated filter paper for 50&#x00025; mortality (LT<sub>50</sub>) using World Health Organization (WHO) test kits following standardised conditions <xref ref-type="bibr" rid="pgen.1000286-WHO2">&#x0005b;22&#x0005d;</xref>. To estimate the LT<sub>50</sub> we first established a time-response curve by exposing approximately 100 individuals to one of six different exposure times (12.5, 25, 50, 100, 150 and 200 min). Mortality was recorded 24 h post exposure and data were fitted by a logistic regression model using logit-transformed probabilities <xref ref-type="bibr" rid="pgen.1000286-Pampel1">&#x0005b;23&#x0005d;</xref> to predict the LT<sub>50</sub>. All analyses were performed using the open source statistical software package R (<ext-link ext-link-type="uri" xlink:href="http://www.r-project.org">http://www.r-project.org</ext-link>). All R-code required to perform these calculations is available from the first author on request. Once the LT<sub>50</sub> was determined, cohorts of 3-day old adult females were split into two groups; one group was exposed to 0.75&#x00025; permethrin and the other group to a control paper which contained only the insecticide carrier (silicone oil). Both groups were exposed for the LT<sub>50</sub> using WHO test tubes and then transferred to holding tubes. In order to examine constitutive differences in gene expression between selected and unselected mosquitoes all individuals were kept in the holding tubes for 48 h before they were killed in 70&#x00025; ethanol. A recovery time of 48 h was chosen to control for potential permethrin-induced gene expression. Vontas <italic>et al.</italic><xref ref-type="bibr" rid="pgen.1000286-Vontas1">&#x0005b;24&#x0005d;</xref> showed that permethrin-induced gene expression regains constitutive levels within 24 h of a non-lethal exposure. To test for permethrin-induced gene expression additional family lines were reared and 3-day old adult females split into two groups. One group was exposed to 0.75&#x00025; permethrin for 30 min and the second group served as a control. After a recovery time of 48 h post exposure four to five female mosquitoes from each group were pooled and RNA extracted. Using RT-PCR gene expression levels of exposed and unexposed individuals were compared in a pair wise <italic>t</italic>-test.</p><p>For all mosquitoes one hind leg was removed for DNA extraction and the remaining body parts were transferred to RNA<italic>later</italic> (Ambion) to prevent RNA degradation. Genomic DNA was extracted from legs using the DNeasy kit (Qiagen) and used to identify each specimen to species and molecular form <xref ref-type="bibr" rid="pgen.1000286-Fanello1">&#x0005b;25&#x0005d;</xref>. The same DNA was used to screen for the presence of the L1014F <xref ref-type="bibr" rid="pgen.1000286-MartinezTorres1">&#x0005b;6&#x0005d;</xref> and L1014S <xref ref-type="bibr" rid="pgen.1000286-Ranson1">&#x0005b;7&#x0005d;</xref> substitutions within the voltage-gated sodium channel protein causing knockdown resistance (<italic>kdr</italic>) by a heated oligonucleotide ligation assay (HOLA) <xref ref-type="bibr" rid="pgen.1000286-Lynd1">&#x0005b;26&#x0005d;</xref>.</p></sec><sec id="s2c"><title>Microarray</title><p>Only mosquitoes identified as members of <italic>A. gambiae s.s.</italic> S form and homozygous for the L1014F <italic>kdr</italic> allele were included in the microarray study. Total RNA was extracted from pools of 10 mosquitoes which were either selected against 0.75&#x00025; permethrin for the LT<sub>50</sub> or not exposed to the insecticide. The quality and quantity of all RNA pools was measured by a spectrophotometer (Nanodrop Technologies) and a random subset was also assessed using a 2100 Bioanalyzer (Agilent Technologies). RNA extraction, amplification and labelling protocols followed those described in M&#x000fc;ller <italic>et al.</italic><xref ref-type="bibr" rid="pgen.1000286-Mller2">&#x0005b;21&#x0005d;</xref>. Labelled targets were hybridised to an updated version of the <italic>A. gambiae detox chip</italic><xref ref-type="bibr" rid="pgen.1000286-David1">&#x0005b;11&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000286-Mller2">&#x0005b;21&#x0005d;</xref> which was printed with a physical rearrangement of the probes (ArrayExpress accession A-MEXP-863). The probes on the microarray include 103 cytochrome P450s, 31 esterases, 35 glutathione S-transferases and 85 additional genes such as peroxidases, reductases, superoxide dismutases, ATP-binding cassette transporters, tissue specific genes and housekeeping genes.</p><p>The microarray experiment compared RNA pools from selected vs. unselected mosquitoes, comprising six independent replicates with dye-swaps (12 arrays in total). As each probe was spotted in replicates of four and measurements were obtained for both red and green wavelengths in each array, a total of 96 measurements per probe were obtained. After visual inspection of each array, spot and background intensities were calculated from the scanned array images using GenePix Pro 5.1 software (Axon Instruments). Raw intensities were then analysed with Limma 2.4 software package <xref ref-type="bibr" rid="pgen.1000286-Smyth1">&#x0005b;27&#x0005d;</xref> running in R. Any spot that showed a median intensity in one or both channels at saturation was excluded from the analysis. For each spot background intensities were subtracted (i.e. method&#x0200a;&#x0003d;&#x0200a;&#x0201c;subtract&#x0201d;) from the total spot intensities and adjusted intensities were transformed into intensity log-ratios and normalised. For the comparison between the two groups, selected vs. unselected, estimates for technical replicates (dye-swaps) were first averaged and then compared between the two groups. A detailed description of the methods used for normalisation and statistical analysis is given in M&#x000fc;ller <italic>et al.</italic><xref ref-type="bibr" rid="pgen.1000286-Mller1">&#x0005b;12&#x0005d;</xref>. All microarray data has been deposited in ArrayExpress (accession E-MTAB-52).</p><p>In terms of absolute fold change our values are likely to underestimate true fold differences between mosquitoes that would survive an LT<sub>50</sub> and those that would not. This is a result of the study design whereby the LT<sub>50</sub> survivors were compared with a control group that would be expected to be a mixture of 50&#x00025; mosquitoes surviving and 50&#x00025; mosquitoes dying after exposure to 0.75&#x00025; permethrin. It was not possible to select a fully susceptible control group due to the expected RNA degradation postmortem. The underestimation of fold changes may occur wherever resistant mosquitoes are compared with their parental line. Details of how this study design limits maximum fold change are given in <xref ref-type="supplementary-material" rid="pgen.1000286.s001">Figure S1</xref>. As a consequence we have chosen to rank our genes by statistical significance (<italic>i.e.</italic>, &#x02212;log<sub>10</sub><italic>P</italic>-value) rather than setting an arbitrary fold change cut-off to filter for candidates.</p></sec><sec id="s2d"><title>Quantitative RT-PCR</title><p>Quantitative RT-PCR was used to validate microarray data and for comparisons with the &#x0201c;Kisumu&#x0201d; strain, a susceptible <italic>A. gambiae s.s.</italic> laboratory colony. An aliquot of 75 ng from each pool of total RNA served as template for making target specific cDNA by reverse transcription in a single multiplex assay using the GenomeLab GeXP Start Kit (Beckman Coulter) and the gene-specific primers in <xref ref-type="table" rid="pgen-1000286-t001">Table 1</xref>. The primers were designed using the eXpres Profiler software (Beckman Coulter) based on cDNA sequences retrieved from the sources given in <xref ref-type="table" rid="pgen-1000286-t001">Table 1</xref>. The GeXP multiplex system uses a combined primer of target-specific and a universal sequence to reverse transcribe mRNA into cDNA. The reverse transcription step was followed by a PCR step in which during the first three cycles amplification was carried out by chimerical forward and reverse primers (<xref ref-type="table" rid="pgen-1000286-t001">Table 1</xref>). For the subsequent cycles (numbers 4 to 35), amplification was carried out using universal forward and universal reverse primers provided by the kit. The PCR conditions were 95&#x000b0;C for 10 min, followed by 35 cycles of 94&#x000b0;C for 30 s, 55&#x000b0;C for 30 s and 68&#x000b0;C for 1 min. Multiplexing primer specificity was confirmed by sequencing the PCR products obtained from single reactions. The universal primers that come with the kit were fluorescently labelled and yielded signals that corresponded to the amount of product in the multiplex reaction. PCR products were quantified with a CEQ 8000 Genetic Analysis System (Beckman Coulter) running a GenomeLab GeXP eXpress analysis program (Beckman Coulter) that computes peak areas for each target. The peak area of a control gene, <italic>S7</italic> (VectorBase: AGAP010592) was used to normalise for variation in total mRNA amount. Normalised peak areas were then log<sub>2</sub>-transformed to approximate a normal distribution.</p><table-wrap id="pgen-1000286-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000286.t001</object-id><label>Table 1</label><caption><title>Oligonucleotide primer sequences used for microarray validation.</title></caption><graphic id="pgen-1000286-t001-1" xlink:href="pgen.1000286.t001"/><table frame="hsides" rules="groups" alternate-form-of="pgen-1000286-t001-1"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Gene</td><td align="left" rowspan="1" colspan="1">Accession no.</td><td align="left" rowspan="1" colspan="1">Primer</td><td align="left" rowspan="1" colspan="1">Sequence (5&#x02032;-3&#x02032;)</td><td align="left" rowspan="1" colspan="1">Concentration</td><td align="left" rowspan="1" colspan="1">Size</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>ABCC11</italic></td><td align="left" rowspan="1" colspan="1">VectorBase:AGAP008436-RA</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TCATCTACCGGGACTTTTCG</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">135 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TCCCAATGAAGCTGGATTTC</named-content></td><td align="left" rowspan="1" colspan="1">50 nM</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>ABCC9</italic></td><td align="left" rowspan="1" colspan="1">VectorBase:AGAP008437-RA</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">AACGTCCACACCGATCTTTC</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">106 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TTCCAATCGCTTTAATTGCC</named-content></td><td align="left" rowspan="1" colspan="1">50 nM</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>COEAE2G</italic></td><td align="left" rowspan="1" colspan="1">VectorBase:AGAP006723-RA</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TGATCAAGAACCTGTCGGTG</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">177 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CGGTAAGCAGATCGACCAAT</named-content></td><td align="left" rowspan="1" colspan="1">150 nM</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP12F4</italic></td><td align="left" rowspan="1" colspan="1">VectorBase:AGAP008018-RA</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GGATCGACGGGAATTCTGTA</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">215 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">AGAACGAGGTCTTTTCCGGT</named-content></td><td align="left" rowspan="1" colspan="1">50 nM</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP4D22</italic></td><td align="left" rowspan="1" colspan="1">VectorBase:AGAP002419-RA</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GTTAGCGTTGTTCTGCACCA</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">184 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GATCTTGAAGTGAAAGGCGG</named-content></td><td align="left" rowspan="1" colspan="1">50 nM</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP4H19</italic></td><td align="left" rowspan="1" colspan="1">VectorBase:AGAP000088-RA</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TTCTCGTGACGCTATTGGTG</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">238 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CTGGTTACGACGACCATGTG</named-content></td><td align="left" rowspan="1" colspan="1">150 nM</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP4H24</italic></td><td align="left" rowspan="1" colspan="1">VectorBase:AGAP000088-RA</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CGCAAGTGTCTAACGAGCAG</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">163 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TCATGACCCTCGAACATGAA</named-content></td><td align="left" rowspan="1" colspan="1">50 nM</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP6AK1</italic></td><td align="left" rowspan="1" colspan="1">VectorBase:AGAP010961-RA</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GCTGCCACCTTCTATATGGC</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">142 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TTTCGCGTCCATATTTGACA</named-content></td><td align="left" rowspan="1" colspan="1">6.2 nM</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP6M2</italic></td><td align="left" rowspan="1" colspan="1">VectorBase:AGAP008212-RA</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TTCGTCGACTCTCCTCACCT</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">199 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GAAATGTACCGGGACTGGTG</named-content></td><td align="left" rowspan="1" colspan="1">50 nM</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP6M3</italic></td><td align="left" rowspan="1" colspan="1">VectorBase:AGAP008213-RA</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GATCAAGTACCGGGTGGAGA</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">229 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TCTGCCCTTATCTTGCACCT</named-content></td><td align="left" rowspan="1" colspan="1">24.4 pM</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP6N1</italic></td><td align="left" rowspan="1" colspan="1">GeneBank:AY028786</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CTACTGGGAAAAGCGAGGTG</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">149 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GAATTCCTCCGAATGGTTGA</named-content></td><td align="left" rowspan="1" colspan="1">50 nM</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP6P3</italic></td><td align="left" rowspan="1" colspan="1">VectorBase:AGAP002865-RA</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">AGCTAATTAACGCGGTGCTG</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">121 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">AAGTGTGGATTCGGAGCGTA</named-content></td><td align="left" rowspan="1" colspan="1">50 nM</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP6Z2</italic></td><td align="left" rowspan="1" colspan="1">VectorBase:AGAP008218-RA</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TTATTTGTCCTGGGTTGTTGAA</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">244 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GTTTCTGCACCGGCAATGTA</named-content></td><td align="left" rowspan="1" colspan="1">50 nM</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>GSTD1-4</italic></td><td align="left" rowspan="1" colspan="1">VectorBase:AGAP004164-RC</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TCGAGCGATCATGTGCTATC</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">222 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">AACGCTAAAGCTTCCCCAAT</named-content></td><td align="left" rowspan="1" colspan="1">50 nM</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>S7</italic></td><td align="left" rowspan="1" colspan="1">VectorBase:AGAP010592-RA</td><td align="left" rowspan="1" colspan="1">forward</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CATTTCGTTGTGAACCCAAA</named-content></td><td align="left" rowspan="1" colspan="1">20 nM</td><td align="left" rowspan="1" colspan="1">128 bp</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">reverse</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">AGTTCATCTCCAGCTCCAGG</named-content></td><td align="left" rowspan="1" colspan="1">0.8 nM</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="nt101"><p>Primer sequences and product size are given without the universals needed for the qPCR method applied.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2e"><title>Cloning <italic>CYP6P3</italic> for Expression in <italic>Escherichia coli</italic></title><p>Messenger RNA from the susceptible lab colony <italic>A. gambiae</italic> &#x0201c;Kisumu&#x0201d; (3-day old adults) was isolated using the PicoPure kit (Arcturus) and cDNA prepared using Superscript III (Invitrogen). Initial efforts to express <italic>CYP6P3</italic> using the <italic>E. coli</italic> OmpA signal peptide as previously described for <italic>CYP6Z2</italic><xref ref-type="bibr" rid="pgen.1000286-McLaughlin1">&#x0005b;15&#x0005d;</xref> were unsuccessful. Therefore, we used another common strategy for P450 expression, which is to replace the natural P450 amino-terminus with a sequence (MALLLAVF) derived from the bovine steroid 17 &#x003b1;-hydroxylase <xref ref-type="bibr" rid="pgen.1000286-Barnes1">&#x0005b;28&#x0005d;</xref>. To introduce the amino-terminal 17&#x003b1; modification the 5&#x02032;-end of <italic>CYP6P3</italic> cDNA was amplified using KOD DNA polymerase (Novagen) with ECG169 (<named-content content-type="gene">5&#x02032;TTT<underline>CATATG</underline>GCTCTGTTATTAGCAGTTTTTGCCGCGTTCATCTTCGCAGTGTCGATCGTG 3&#x02032;</named-content>), introducing a <italic>Nde</italic>I restriction site at the initiation codon (underlined), and ECG137 (<named-content content-type="gene">5&#x02032;-AT<underline>GAATTC</underline>TACAACTTTTCCACCTTCAAG -3&#x02032;</named-content>) complementary to the 3&#x02032;-end of the <italic>CYP6P3</italic> cDNA, and introducing an <italic>Eco</italic>RI site (underlined). The resulting 17&#x003b1;-CYP6P3 was ligated into pCWompA2 via <italic>Nde</italic>I and <italic>Eco</italic>RI to create pCW::17&#x003b1;-cyp6p3. The construct was sequenced and compared with the database sequence of <italic>CYP6P3</italic> (GenBank:AAL93295). In addition to the four amino acid substitutions to the membrane anchoring sequence as a result of the 17&#x003b1; modification (E2A, I4L, N5L, and L8F &#x02013; numbering relative to published sequenced), there were two nucleotide changes that encoded amino acid substitutions R154W and L292V. These nucleotides changes were are also present in <italic>CYP6P3</italic> amplified from Kisumu genomic DNA and are therefore not due to PCR errors.</p></sec><sec id="s2f"><title>Preparation of <italic>E. coli</italic> Membranes for Functional CYP6P3</title><p>For functional expression of CYP6P3 and its redox partner cytochrome P450 reductase (CPR), competent <italic>E. coli</italic> DH5&#x003b1; cells were co-transformed with pCW::17&#x003b1;-cyp6p3 and pACYC-AgCPR. This transformant was grown in 0.4 l of Terrific Broth with ampicillin and chloramphenicol selection at 37&#x000b0;C until the optical density at 595 nm reached 0.8 units. The culture was then cooled to 25&#x000b0;C, supplemented with 0.5 mM 5-aminolevulinic acid (Melford, UK) and 1 mM isopropyl &#x003b2;-D-1-thiogalactopyranoside (Melford) before incubation continued at 25&#x000b0;C with orbital shaking at 150 rpm. The cells were harvested and membranes prepared as described previously <xref ref-type="bibr" rid="pgen.1000286-McLaughlin1">&#x0005b;15&#x0005d;</xref>. P450 function was quantified by CO-difference spectroscopy <xref ref-type="bibr" rid="pgen.1000286-Omura1">&#x0005b;29&#x0005d;</xref> and CPR activity was estimated by cytochrome <italic>c</italic> reductase activity <xref ref-type="bibr" rid="pgen.1000286-Pritchard1">&#x0005b;30&#x0005d;</xref>. CYP6P3 was expressed at 50&#x02013;100 nmol of P450 litre of culture. The isolated bacterial membranes contained 0.5 nmol of CYP6P3 per mg protein and the specific activity of <italic>CPR</italic> was 61 nmol cytochrome c reduced min<sup>&#x02212;1</sup> mg<sup>&#x02212;1</sup> protein. Total protein concentration was determined by Bradford assay, with bovine serum albumin standards.</p></sec><sec id="s2g"><title>Pyrethroid Metabolism Assays</title><p>Deltamethrin and permethrin (Chemservice, West Chester, PA) were incubated with 0.25 &#x000b5;M CYP6P3 in 0.2 M Tris.HCl, pH 7.4, 0.25 mM MgCl<sub>2</sub> in the presence or absence of an NADPH generating system (1 mM glucose-6-phosphate (Melford), 0.1 mM NADP<sup>&#x0002b;</sup> (Melford), 1 unit ml<sup>&#x02212;1</sup> glucose-6-phosphate dehydrogenase (G6PDH) in a total volume of 100 &#x000b5;l. Reactions were carried out in triplicate at 30&#x000b0;C with 1,200 rpm shaking. Samples were pre-warmed for 5 min before reactions were initiated by addition of the membrane preparation. Reactions were stopped with 100 &#x000b5;l of acetonitrile and incubated for a further 20 min to ensure that all pyrethroid was dissolved.</p><p>The quenched reactions were centrifuged at 20,000 <italic>g</italic> for 10 min before transferring the supernatant to glass HPLC vials. 100 &#x000b5;l of the supernatant was loaded onto a mobile phase with a flow rate of 1 ml min<sup>&#x02212;1</sup> and 23&#x000b0;C for separation on a 250 mm C18 column (Acclaim 120, Dionex). Time-trial reactions were run with a linear gradient from 0&#x00025; to 90&#x00025; acetonitrile in water (v/v) over the first 6 min, 90&#x00025; was then held for 10 min before returning 0&#x00025; with a linear gradient over 2 min followed by equilibration with 0&#x00025; for another 4 min. Pyrethroid elution was monitored by absorption at 232 nm and quantified by peak integration (Chromeleon, Dionex).</p><p>For kinetics of deltamethrin, varying concentrations of substrate (0.5&#x02013;16 &#x000b5;M) were used. Deltamethrin concentrations were determined by HPLC as describe above, but using an isocratic mobile phase with 90&#x00025; acetonitrile in water. Rates of deltamethrin turnover from three independent reactions were plotted versus deltamethrin substrate concentration. <italic>K</italic><sub>m</sub> and V<sub>max</sub> were determined using SigmaPlot v10.0 (Systat Software, Inc) by fitting to the Michaelis-Menton equation using non-linear regression.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Spectrum of Permethrin Susceptibility</title><p>Before selecting individuals the LT<sub>50</sub> to 0.75&#x00025; permethrin was determined by exposing 98 to 110 individuals per time point and sex (<xref ref-type="fig" rid="pgen-1000286-g001">Figure 1</xref>). Using logistic regression models we estimated an LT<sub>50</sub> of 122 min for females and 95 min for males. Mortality rates for a WHO standard 1 h exposure were 16.8&#x00025; and 30.5&#x00025; for females and males, respectively (<xref ref-type="fig" rid="pgen-1000286-g001">Figure 1</xref>). Mortality in the controls was 2.3&#x00025; for females (<italic>N</italic>&#x0200a;&#x0003d;&#x0200a;171) and 2.1&#x00025; for males (<italic>N</italic>&#x0200a;&#x0003d;&#x0200a;116).</p><fig id="pgen-1000286-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000286.g001</object-id><label>Figure 1</label><caption><title>Spectrum of permethrin susceptibility in <italic>A. gambiae s.l.</italic> from Dodowa, southern Ghana.</title><p>Proportion of 3-day old adult <italic>A. gambiae s.l.</italic> individuals killed as a function of exposure time to 0.75&#x00025; permethrin following WHO standard protocols <xref ref-type="bibr" rid="pgen.1000286-WHO2">&#x0005b;22&#x0005d;</xref>. Dots represent summaries from performed susceptibility tests with between 98 and 110 individuals per time point and sex. Time-response curves were fitted to data using logit analysis <xref ref-type="bibr" rid="pgen.1000286-Pampel1">&#x0005b;23&#x0005d;</xref>. Dotted lines indicate LT<sub>50</sub>s which were 2 h 2 min and 1 h 35 min for females and males, respectively.</p></caption><graphic xlink:href="pgen.1000286.g001"/></fig></sec><sec id="s3b"><title>Species Composition and Genotypes</title><p>A total of 333 <italic>A. gambiae s.l.</italic> females were stored for gene expression studies and identified to species level, molecular form and <italic>kdr</italic> genotype (<xref ref-type="table" rid="pgen-1000286-t002">Table 2</xref>). The majority (99.4&#x00025;) of the sampled mosquitoes were <italic>A. gambiae s.s.</italic> belonging to the molecular S form, and only two individuals in the control group were M form. The L1014S <italic>kdr</italic> mutation was detected in three individuals, although it was not possible to confirm this result by sequencing. There was no difference in L1014F frequencies between the control and selected groups (Fisher's exact test, <italic>P</italic>&#x0200a;&#x0003d;&#x0200a;0.22). This latter mutation was close to fixation with 91.3&#x00025; of the screened individuals in the control group being homozygous for the L1014F mutation (<xref ref-type="table" rid="pgen-1000286-t002">Table 2</xref>).</p><table-wrap id="pgen-1000286-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000286.t002</object-id><label>Table 2</label><caption><title>Distribution of S and M molecular forms and <italic>kdr</italic> allele frequencies in the control and selected group collected for gene expression analysis.</title></caption><graphic id="pgen-1000286-t002-2" xlink:href="pgen.1000286.t002"/><table frame="hsides" rules="groups" alternate-form-of="pgen-1000286-t002-2"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Molecular form</td><td colspan="6" align="left" rowspan="1"><italic>kdr</italic> allele frequency</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R<sub>W</sub>,R<sub>W</sub></td><td align="left" rowspan="1" colspan="1">R<sub>W</sub>,&#x0002b;</td><td align="left" rowspan="1" colspan="1">R<sub>W</sub>,R<sub>E</sub><xref ref-type="table-fn" rid="nt105">1</xref></td><td align="left" rowspan="1" colspan="1">R<sub>E</sub>,R<sub>E</sub></td><td align="left" rowspan="1" colspan="1">R<sub>E</sub>,&#x0002b;</td><td align="left" rowspan="1" colspan="1">&#x0002b;,&#x0002b;</td></tr></thead><tbody><tr><td colspan="7" align="left" rowspan="1"><italic>Control group</italic> (172)</td></tr><tr><td align="left" rowspan="1" colspan="1">S</td><td align="left" rowspan="1" colspan="1">91.3&#x00025; (157)</td><td align="left" rowspan="1" colspan="1">5.8&#x00025; (10)</td><td align="left" rowspan="1" colspan="1">1.7&#x00025; (3)</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">M</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1.2&#x00025; (2)</td></tr><tr><td colspan="7" align="left" rowspan="1"><italic>Selected group</italic> (161)</td></tr><tr><td align="left" rowspan="1" colspan="1">S</td><td align="left" rowspan="1" colspan="1">95.0&#x00025; (153)</td><td align="left" rowspan="1" colspan="1">5.0&#x00025; (8)</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">M</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td></tr></tbody></table><table-wrap-foot><fn id="nt102"><p>Figures in brackets show the number of specimens scored.</p></fn><fn id="nt103"><p>R<sub>W</sub>: L1014F <italic>kdr</italic> substitution.</p></fn><fn id="nt104"><p>R<sub>E</sub>: L1014S <italic>kdr</italic> substitution.</p></fn><fn id="nt105"><label>1</label><p>not confirmed by sequencing.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3c"><title>Gene Expression</title><p>All specimens included in the microarray analysis were <italic>A. gambiae s.s.</italic>, molecular S form and homozygous for the L1014F <italic>kdr</italic> mutation to minimise confounding effects. Three P450s were consistently (very low <italic>P</italic>-values) expressed at higher levels in LT<sub>50</sub>-selected vs. unexposed mosquitoes; <italic>CYP6P3</italic>, <italic>CYP4H24</italic> and <italic>CYP4H19</italic> (<xref ref-type="fig" rid="pgen-1000286-g002">Figure 2</xref>, <xref ref-type="table" rid="pgen-1000286-t003">Table 3</xref>). <italic>CYP6P3</italic> and <italic>CYP4H19</italic> were 1.6-fold over-expressed and <italic>CYP4H24</italic> was 1.5-fold over-expressed in specimens surviving the LT<sub>50</sub>.</p><fig id="pgen-1000286-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000286.g002</object-id><label>Figure 2</label><caption><title>Microarray analysis of loci showing differences in expression levels between LT<sub>50</sub>-selected and unselected specimens.</title><p>Each dot represents the mean estimates, <italic>P</italic>-value <italic>vs.</italic> fold difference for one unique probe on the microarray. Names are given for the 10 statistically most significant genes (values are given in <xref ref-type="table" rid="pgen-1000286-t003">Table 3</xref>). To account for multiple testing, <italic>P</italic>-values were adjusted adopting the approach of Benjamini and Hochberg <xref ref-type="bibr" rid="pgen.1000286-Benjamini1">&#x0005b;41&#x0005d;</xref> to control for the false discovery rate as described in Smyth <xref ref-type="bibr" rid="pgen.1000286-Smyth1">&#x0005b;27&#x0005d;</xref>.</p></caption><graphic xlink:href="pgen.1000286.g002"/></fig><table-wrap id="pgen-1000286-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000286.t003</object-id><label>Table 3</label><caption><title>Microarray results of top ten differentially expressed genes between selected and unselected mosquitoes.</title></caption><graphic id="pgen-1000286-t003-3" xlink:href="pgen.1000286.t003"/><table frame="hsides" rules="groups" alternate-form-of="pgen-1000286-t003-3"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Gene</td><td align="left" rowspan="1" colspan="1">Accession no.</td><td align="left" rowspan="1" colspan="1">Function</td><td align="left" rowspan="1" colspan="1">Location</td><td align="left" rowspan="1" colspan="1">Measured fold</td><td align="left" rowspan="1" colspan="1">Putative fold<xref ref-type="table-fn" rid="nt106">1</xref></td><td align="left" rowspan="1" colspan="1"><italic>P</italic>-value<xref ref-type="table-fn" rid="nt107">2</xref></td></tr></thead><tbody><tr><td colspan="7" align="left" rowspan="1">Overexpressed in selected mosquitoes</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP6P3</italic></td><td align="left" rowspan="1" colspan="1">VectorBase: AGAP002865-RA</td><td align="left" rowspan="1" colspan="1">Cytochrome P450</td><td align="left" rowspan="1" colspan="1">2R</td><td align="left" rowspan="1" colspan="1">1.61</td><td align="left" rowspan="1" colspan="1">2.82</td><td align="left" rowspan="1" colspan="1">6.69&#x000d7;10<sup>&#x02212;19</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP4H24</italic></td><td align="left" rowspan="1" colspan="1">VectorBase: AGAP000088-RA</td><td align="left" rowspan="1" colspan="1">Cytochrome P450</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">1.47</td><td align="left" rowspan="1" colspan="1">2.21</td><td align="left" rowspan="1" colspan="1">6.69&#x000d7;10<sup>&#x02212;19</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP4H19</italic></td><td align="left" rowspan="1" colspan="1">VectorBase: AGAP000088-RA</td><td align="left" rowspan="1" colspan="1">Cytochrome P450</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">1.61</td><td align="left" rowspan="1" colspan="1">2.83</td><td align="left" rowspan="1" colspan="1">1.63&#x000d7;10<sup>&#x02212;16</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP6AK1</italic></td><td align="left" rowspan="1" colspan="1">VectorBase: AGAP010961-RA</td><td align="left" rowspan="1" colspan="1">Cytochrome P450</td><td align="left" rowspan="1" colspan="1">3L</td><td align="left" rowspan="1" colspan="1">1.27</td><td align="left" rowspan="1" colspan="1">1.57</td><td align="left" rowspan="1" colspan="1">1.19&#x000d7;10<sup>&#x02212;08</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>COEAE1D</italic></td><td align="left" rowspan="1" colspan="1">VectorBase: AGAP005756-RA</td><td align="left" rowspan="1" colspan="1">Carboxylesterase</td><td align="left" rowspan="1" colspan="1">2L</td><td align="left" rowspan="1" colspan="1">1.30</td><td align="left" rowspan="1" colspan="1">1.66</td><td align="left" rowspan="1" colspan="1">3.71&#x000d7;10<sup>&#x02212;08</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP6M2</italic></td><td align="left" rowspan="1" colspan="1">VectorBase: AGAP008212-RA</td><td align="left" rowspan="1" colspan="1">Cytochrome P450</td><td align="left" rowspan="1" colspan="1">3R</td><td align="left" rowspan="1" colspan="1">1.29</td><td align="left" rowspan="1" colspan="1">1.64</td><td align="left" rowspan="1" colspan="1">6.28&#x000d7;10<sup>&#x02212;07</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>ABCC11</italic></td><td align="left" rowspan="1" colspan="1">VectorBase: AGAP008436-RA</td><td align="left" rowspan="1" colspan="1">ABC transporter</td><td align="left" rowspan="1" colspan="1">3R</td><td align="left" rowspan="1" colspan="1">1.19</td><td align="left" rowspan="1" colspan="1">1.38</td><td align="left" rowspan="1" colspan="1">1.15&#x000d7;10<sup>&#x02212;06</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>ABCC9</italic></td><td align="left" rowspan="1" colspan="1">VectorBase: AGAP008437-RA</td><td align="left" rowspan="1" colspan="1">ABC transporter</td><td align="left" rowspan="1" colspan="1">3R</td><td align="left" rowspan="1" colspan="1">1.30</td><td align="left" rowspan="1" colspan="1">1.66</td><td align="left" rowspan="1" colspan="1">2.01&#x000d7;10<sup>&#x02212;06</sup></td></tr><tr><td colspan="7" align="left" rowspan="1">Overexpressed in unselected mosquitoes</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP6N1</italic></td><td align="left" rowspan="1" colspan="1">GenBank: AY028786</td><td align="left" rowspan="1" colspan="1">Cytochrome P450</td><td align="left" rowspan="1" colspan="1">3R</td><td align="left" rowspan="1" colspan="1">&#x02212;1.20</td><td align="left" rowspan="1" colspan="1">&#x02212;1.35</td><td align="left" rowspan="1" colspan="1">1.84&#x000d7;10<sup>&#x02212;07</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CYP12F4</italic></td><td align="left" rowspan="1" colspan="1">VectorBase: AGAP008018-RA</td><td align="left" rowspan="1" colspan="1">Cytochrome P450</td><td align="left" rowspan="1" colspan="1">3R</td><td align="left" rowspan="1" colspan="1">&#x02212;1.19</td><td align="left" rowspan="1" colspan="1">&#x02212;1.32</td><td align="left" rowspan="1" colspan="1">3.67&#x000d7;10<sup>&#x02212;06</sup></td></tr></tbody></table><table-wrap-foot><fn id="nt106"><label>1</label><p>Gives the estimated ratio in gene expression levels if survivors were directly compared with dead mosquitoes (See <xref ref-type="supplementary-material" rid="pgen.1000286.s001">Figure S1</xref> for its calculation).</p></fn><fn id="nt107"><label>2</label><p>To account for multiple testing, <italic>P</italic>-values were adjusted adopting the approach of Benjamini and Hochberg <xref ref-type="bibr" rid="pgen.1000286-Benjamini1">&#x0005b;41&#x0005d;</xref> to control for the false discovery rate as described in Smyth <xref ref-type="bibr" rid="pgen.1000286-Smyth1">&#x0005b;27&#x0005d;</xref>.</p></fn></table-wrap-foot></table-wrap><p>The same RNA pools used in the microarray analysis were additionally evaluated by multiplex quantitative reverse transcription (RT) PCR for 14 selected genes (<xref ref-type="table" rid="pgen-1000286-t001">Table 1</xref>). The transcripts were selected from the pool of genes that were differentially expressed in the microarray analysis. Two genes, <italic>CYP4H19</italic> and <italic>COEAE2G</italic> were removed from the analysis due to missing PCR products for some of the RNA pools. Both methods were in concordance for several genes, though not for all, including <italic>CYP6P3</italic>, <italic>CYP6M2</italic>, <italic>CYP6AK1</italic>, <italic>GSTD1-4</italic>, <italic>ABCC9</italic> and <italic>CYP6Z2</italic> (<xref ref-type="fig" rid="pgen-1000286-g003">Figure 3A</xref>). For all other genes, <italic>ABCC11</italic>, <italic>CYP4D22</italic>, <italic>CYP4H24</italic>, <italic>CYP6M3</italic>, <italic>CYP6N1</italic> and <italic>CYP12F4</italic> the lack of concurrence between the two methods is probably related to low levels of fold change <xref ref-type="bibr" rid="pgen.1000286-Morey1">&#x0005b;31&#x0005d;</xref>.</p><fig id="pgen-1000286-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000286.g003</object-id><label>Figure 3</label><caption><title>Microarray validation by quantitative RT-PCR.</title><p>(A) Correlation between microarray data and RT-PCR of selected genes given in <xref ref-type="table" rid="pgen-1000286-t001">Table 1</xref> (<italic>CYP4H19</italic> and <italic>COEAE2G</italic> were removed from the analysis). While both microarray and multiplex RT-PCR showed similar fold differences for <italic>CYP6P3</italic>, the overall correlation was weak (<italic>r</italic>&#x0200a;&#x0003d;&#x0200a;0.46, <italic>P</italic>&#x0200a;&#x0003d;&#x0200a;0.129). (B) <italic>CYP6P3</italic> expression levels including additional specimens (Mean values&#x000b1;S.E.M.). Unselected: unselected field specimens (<italic>N</italic>&#x0200a;&#x0003d;&#x0200a;14 replicates, <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;140 individuals). Selected: LT<sub>50</sub>-selected specimens (<italic>N</italic>&#x0200a;&#x0003d;&#x0200a;15 replicates, <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;150 individuals). Kisumu: susceptible lab strain (<italic>N</italic>&#x0200a;&#x0003d;&#x0200a;3 replicates, <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;30 individuals). <italic>CYP6P3</italic> levels in the susceptible Kisumu lab strain were 1.7-fold lower than in the selected, field-caught mosquitoes (one-sided <italic>t</italic>-test, <italic>P</italic>&#x0003c;0.05). Note that the <italic>y</italic>-axis shows normalised, log-transformed expression levels.</p></caption><graphic xlink:href="pgen.1000286.g003"/></fig><p>On the basis of having the most consistent gene expression pattern, the catalytic properties of CYP6P3 enzyme was further investigated by heterologous expression in <italic>E. coli</italic>. The comparison of <italic>CYP6P3</italic> expression levels between LT<sub>50</sub>-selected mosquitoes and a susceptible laboratory (Kisumu, <italic>A. gambiae s.s.</italic>) strain also showed increased levels in the wild mosquito population (<xref ref-type="fig" rid="pgen-1000286-g003">Figure 3B</xref>), showing additional evidence for an association between <italic>CYP6P3</italic>-overexpression and permethrin resistance. A comparison of <italic>CYP6P3</italic> expression levels between permethrin-exposed and unexposed female siblings 48 h post exposure showed no sign of gene induction (pair wise <italic>t</italic>-test, <italic>P</italic>-value&#x0200a;&#x0003d;&#x0200a;0.49, <italic>N</italic>&#x0200a;&#x0003d;&#x0200a;7 families; data not shown). Hence, overexpression of <italic>CYP6P3</italic> may be assumed to be constitutive rather than induced upon permethrin exposure.</p></sec><sec id="s3d"><title>Pyrethroid Metabolism</title><p>CYP6P3 was co-expressed with <italic>A. gambiae</italic> cytochrome P450 reductase (CPR) in <italic>E. coli</italic> to produce a functional monooxygenase complex, and the ability of CYP6P3 to metabolise permethrin was evaluated from time-dependant elimination of a 10 &#x000b5;M mixture of four isomers. Permethrin eluted with R and S <italic>trans</italic>-isomers at 16.1 min and R and S <italic>cis</italic>-isomers at 17.4 min in HPLC analysis. In the absence of NADPH there was no significant change in permethrin concentration over the 30 min incubation period (<xref ref-type="fig" rid="pgen-1000286-g004">Figures 4A</xref> and <xref ref-type="fig" rid="pgen-1000286-g005">5A</xref>). With the NADPH regeneration system included, 72&#x00025; of the total permethrin was eliminated in 30 min (<xref ref-type="fig" rid="pgen-1000286-g004">Figure 4B</xref>) with a steady rate of elimination (<xref ref-type="fig" rid="pgen-1000286-g005">Figure 5A</xref>). This indicates a turnover of 0.59&#x000b1;0.04 min<sup>&#x02212;1</sup>, (slope from linear regression&#x000b1;S.E.M.) for the <italic>trans</italic>-permethrin isomers and 0.37&#x000b1;0.02 min<sup>&#x02212;1</sup> for the <italic>cis</italic>-permethrin isomers (combined rate of 0.97&#x000b1;0.06 min<sup>&#x02212;1</sup>).</p><fig id="pgen-1000286-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000286.g004</object-id><label>Figure 4</label><caption><title>HPLC chromatograms of CYP6P3 reactions.</title><p>(A) and (B) show CYP6P3 reactions with 10 &#x000b5;M permethrin. (C) and (D) show CYP6P3 reactions with 10 &#x000b5;M deltamethrin. Substrate peaks for <italic>cis-</italic> and <italic>trans-</italic>permethrin stereoisomers and deltamethrin are indicated. (B) and (D) are overlaid traces of reactions quenched after 0 min (light trace) and 30 min (dark trace) showing substrate elimination in the presence of NADPH. (A) and (C) are overlaid negative control reactions quenched after 0 and 30 min in the absence of NADPH. Putative NADPH-dependant metabolite peaks are indicated by arrows.</p></caption><graphic xlink:href="pgen.1000286.g004"/></fig><fig id="pgen-1000286-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000286.g005</object-id><label>Figure 5</label><caption><title>Time course of pyrethroid metabolism.</title><p>(A) Reactions were performed at 30&#x000b0;C with 10 &#x000b5;M deltamethrin or (B) 10 &#x000b5;M permethrin stereoisomer mixture. Concentrations were determined by HPLC peak integration (Mean values&#x000b1;S.E.M., <italic>N</italic>&#x0200a;&#x0003d;&#x0200a;3).</p></caption><graphic xlink:href="pgen.1000286.g005"/></fig><p>CYP6P3 activity was also tested against an alpha-cyano pyrethroid, deltamethrin, commonly used on insecticide-treated bednets. Deltamethrin eluted at 14.5 min and like permethrin, NADPH-dependent elimination by CYP6P3 was observed (<xref ref-type="fig" rid="pgen-1000286-g004">Figures 4C, 4D</xref>, and <xref ref-type="fig" rid="pgen-1000286-g005">5B</xref>). The single isomer at 10 &#x000b5;M was turned over slightly slower than permethrin at a constant rate of 0.86&#x000b1;0.03 min<sup>&#x02212;1</sup>. Deltamethrin metabolism was studied in greater kinetic detail due its availability as a single isomer. Analysis of initial metabolic rate (5 min reactions) in response to deltamethrin concentration revealed Michaelis-Menten kinetics: the V<sub>max</sub> was 1.8&#x000b1;0.2 min<sup>&#x02212;1</sup> and the <italic>K</italic><sub>m</sub> was 5.9&#x000b1;1.2 &#x000b5;M (&#x000b1;S.E.M., <italic>N</italic>&#x0200a;&#x0003d;&#x0200a;3).</p></sec></sec><sec id="s4"><title>Discussion</title><p>In this study, we selected wild-caught mosquitoes from a highly permethrin resistant field population in southern Ghana against the insecticide permethrin. Using a custom made microarray we identified <italic>CYP6P3</italic>, a P450 that was overexpressed in mosquitoes surviving exposure to 0.75&#x00025; permethrin for 2 h, the time that kills 50&#x00025; of the mosquito population. Heterologous expression of CYP6P3 in <italic>E. coli</italic> yielded a protein that metabolises permethrin and deltamethrin. This is the first study to identify a gene encoding for an enzyme that mediates pyrethroid detoxification in the malaria vector <italic>A. gambiae s.s.</italic>. As our findings are based on the study of gene expression in wild-caught, phenotyped mosquitoes, the results are of significant importance in the field context.</p><p>3-day old females of the mosquito population under study showed 83&#x00025; survival rate at the WHO diagnostic to 0.75&#x00025; permethrin for 1 h. To our knowledge, this is the highest survival rate reported against permethrin in an <italic>A. gambiae</italic> field population to date. This population has a high frequency of the L1014F <italic>kdr</italic> allele, which confers resistance to pyrethroids and DDT <xref ref-type="bibr" rid="pgen.1000286-MartinezTorres1">&#x0005b;6&#x0005d;</xref>. The population is almost fixed with 91&#x00025; of screened individuals found to be homozygous for the L1014F substitution at the this locus, a 12&#x00025; increase compared to a survey conducted in 2002 at the same field site <xref ref-type="bibr" rid="pgen.1000286-Yawson1">&#x0005b;18&#x0005d;</xref>. There has been much debate over the extent to which target-site and metabolic resistance mechanisms contribute to the observed phenotype <xref ref-type="bibr" rid="pgen.1000286-NGuessan1">&#x0005b;3&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000286-Ranson1">&#x0005b;7&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000286-Reimer1">&#x0005b;32&#x0005d;</xref>. To exclude any possible effect of known target-site mutations we performed all gene expression analyses only on RNA extracted from specimens homozygous for the L1014F <italic>kdr</italic> type. This is a considerable improvement over previous expression studies which were potentially confounded by comparing the susceptible Kisumu strain with resistant laboratory strains having either the L1014S <xref ref-type="bibr" rid="pgen.1000286-David1">&#x0005b;11&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000286-Nikou1">&#x0005b;13&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000286-Vontas1">&#x0005b;24&#x0005d;</xref> or L1014F <xref ref-type="bibr" rid="pgen.1000286-Mller1">&#x0005b;12&#x0005d;</xref><italic>kdr</italic> mutation. Furthermore, in the field population studied L1014F allele was close to fixation and hence the observed variability in resistance phenotype is most likely attributable to an additional mechanism. The time-response, showing mortality as a function of exposure time to 0.75&#x00025; permethrin, is represented by a very broad symmetrically shaped sigmoid curve. This implies that the population has a broad distribution of resistant phenotypes <xref ref-type="bibr" rid="pgen.1000286-Peleg1">&#x0005b;33&#x0005d;</xref> which suggests that there are multiple resistance mechanisms present in the population.</p><p>Three P450s up-regulated in the permethrin-selected specimens showed good accordance between the microarray and RT-PCR data, including <italic>CYP6P3</italic>, <italic>CYP6M2</italic> and <italic>CYP6AK1</italic>. P450s are an abundant family of enzymes which can mediate resistance to all classes of insecticides and their up-regulation has been documented in a broad range of insect species <xref ref-type="bibr" rid="pgen.1000286-Feyereisen1">&#x0005b;8&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000286-Li1">&#x0005b;9&#x0005d;</xref>. Although up-regulation has been identified for a large number of P450s in insecticide resistant insects, studies of catalytic activity are generally limited <xref ref-type="bibr" rid="pgen.1000286-Li1">&#x0005b;9&#x0005d;</xref>. To date two <italic>A. gambiae</italic> P450s (<italic>CYP6Z1</italic> and <italic>CYP6Z2</italic>) have been functionally characterised <xref ref-type="bibr" rid="pgen.1000286-Chiu1">&#x0005b;14&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000286-McLaughlin1">&#x0005b;15&#x0005d;</xref>. While CYP6Z1 is capable of metabolising DDT <xref ref-type="bibr" rid="pgen.1000286-Chiu1">&#x0005b;14&#x0005d;</xref> and CYP6Z2 binds to pyrethroids, a catalytic capacity could not be shown for pyrethroids <xref ref-type="bibr" rid="pgen.1000286-McLaughlin1">&#x0005b;15&#x0005d;</xref>. The current study focused on the characterisation of CYP6P3 because there was a strong association between gene expression and resistance phenotype. CYP6P3 is the first enzyme with a demonstrated potential for catalytic activity with pyrethroids in <italic>A. gambiae</italic>. Intriguingly, <italic>CYP6P9</italic>, the <italic>A. funestus</italic> ortholog of <italic>CYP6P3</italic><xref ref-type="bibr" rid="pgen.1000286-Amenya1">&#x0005b;34&#x0005d;</xref>, is located within a major Quantitative Trait Locus (QTL) conferring pyrethroid resistance <xref ref-type="bibr" rid="pgen.1000286-Wondji1">&#x0005b;35&#x0005d;</xref> and overexpressed in adults of the pyrethroid resistant FUMOZ-R strain <xref ref-type="bibr" rid="pgen.1000286-Amenya2">&#x0005b;36&#x0005d;</xref>. As both the QTL marker and the <italic>A. funestus CYP6P9</italic> locus are physically mapped to the same region on chromosome 2R, it has been postulated that up-regulation is mediated via mutations in <italic>cis</italic>-acting elements <xref ref-type="bibr" rid="pgen.1000286-Amenya2">&#x0005b;36&#x0005d;</xref>. In <italic>A. gambiae s.s.</italic> the question whether <italic>CYP6P3</italic> is <italic>cis</italic>- or <italic>trans</italic>-regulated remains unanswered and further studies are needed to identify how up-regulation is controlled. This information will facilitate the development of expression-associated DNA markers that would allow screening of wild populations for the presence of metabolic resistance alleles.</p><p>The second P450 which showed convincing evidence for association with permethrin-resistance was <italic>CYP6M2</italic>. Moreover, <italic>CYP6M2</italic> has previously been identified in a colonised laboratory strain from the same field site <xref ref-type="bibr" rid="pgen.1000286-Mller1">&#x0005b;12&#x0005d;</xref>. Enzyme characterisation of CYP6M2 is currently underway.</p><p>The third P450, <italic>CYP6AK1</italic>, has not previously been associated with pyrethroid resistance and was down-regulated in the DDT-resistant ZAN/U strain <xref ref-type="bibr" rid="pgen.1000286-David1">&#x0005b;11&#x0005d;</xref>. <italic>CYP6AK1</italic> has not been investigated further, but this gene may become an interesting candidate if found in future studies.</p><p>We expressed the full-length cDNA of CYP6P3 in <italic>E. coli</italic> along with its cognate redox partner CPR to produce a functional enzyme for characterisation studies. Consistent with a role in detoxification, CYP6P3 was found to metabolise permethrin. Permethrin consists of four isomers: (R) <italic>cis</italic>, (R) <italic>trans</italic>, (S) <italic>cis</italic>, (S) <italic>trans</italic>, and it is the <italic>cis</italic> isomers that has greater insecticidal activity, possibly due to slower metabolism <xref ref-type="bibr" rid="pgen.1000286-Shono1">&#x0005b;37&#x0005d;</xref>. Since two peak mixtures of <italic>cis</italic> R/S and <italic>trans</italic> R/S isomers are separated by HPLC chromatography, rates of metabolism of individual isomers could not be determined. However, both (1RS) <italic>cis</italic> and (1RS) <italic>trans</italic> isomers were eliminated from enzyme reactions indicating that metabolism of the active form occurs. Moreover the enzyme was efficient in metabolising deltamethrin, which is widely used in agriculture and in the production of insecticide-treated bednets, further emphasising a potentially important role in metabolic resistance.</p><p>Modest rates of metabolism of the pyrethroids by the heterologously expressed CYP6P3 were observed. Substrate turnover values were in the range 0.5&#x02013;2 min<sup>&#x02212;1</sup>, which were 5 to 10-fold slower than the rates observed for the <italic>in vitro</italic> P450 metabolism of pyrethroids reported from other species; the lepidopteran CYP6B8 has a V<sub>max</sub> for &#x003b1;-cypermethrin of 13 min<sup>&#x02212;1</sup><xref ref-type="bibr" rid="pgen.1000286-Li2">&#x0005b;38&#x0005d;</xref> whereas rat CYP3A2 has 14-fold higher turnover than CYP6P3, although the K<sub>m</sub> for deltamethrin is not significantly different <xref ref-type="bibr" rid="pgen.1000286-Godin1">&#x0005b;39&#x0005d;</xref>. This could potentially be due to the absence of cytochrome b<sub>5</sub> in our system, which is known to enhance the activity of some P450s <xref ref-type="bibr" rid="pgen.1000286-Feyereisen1">&#x0005b;8&#x0005d;</xref>. Indeed, increased levels of cytochrome b<sub>5</sub> are associated with P450 mediated insecticide resistance in some insects and are directly involved in CYP6D1 mediated cypermethrin metabolism in the house fly <xref ref-type="bibr" rid="pgen.1000286-Zhang1">&#x0005b;40&#x0005d;</xref>. Investigations are underway to examine the influence of cytochrome b<sub>5</sub> on metabolism and to further define the molecular interactions of pyrethroids and other insecticides with CYP6P3.</p><p>Our data demonstrates that a P450, <italic>CYP6P3</italic> is up-regulated in highly permethrin resistant <italic>A. gambiae s.s.</italic> mosquitoes in the field and functional characterisation of the enzyme strongly suggest that CYP6P3 metabolises both permethrin and deltamethrin. The overexpression of its ortholog in <italic>A. funestus</italic> provides further support to the importance of this enzyme for pyrethroid resistance in malaria vectors. <italic>CYP6M2</italic> was also overexpressed in this study and a study on a laboratory strain colonised from the same area <xref ref-type="bibr" rid="pgen.1000286-Mller1">&#x0005b;12&#x0005d;</xref> and thus merits further investigation. Yet, although its origin is from the same locality as the existing population, the previous analysis did not detect the change in <italic>CYP6P3</italic>. The current study emphasises the importance of studying metabolic resistance in natural mosquito populations.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pgen.1000286.s001"><label>Figure S1</label><caption><p>Transformation of fold differences for mixed RNA pools. (A) A simplified mathematical model that adjusts for limitations in the fold change of mRNA levels if RNA pools from insecticide-selected (<italic>S</italic>) <italic>vs.</italic> a mixed (insecticide-selected combined with unselected) group (<italic>M</italic>) of mosquitoes are compared. The transformed ratio, <italic>S</italic>/<italic>D</italic> gives the ratio as if RNA could be extracted from survivors (<italic>S</italic>) and dead (<italic>D</italic>) mosquitoes alike and would be directly compared, a situation which may not be possible for selection experiments due to post-mortem RNA degradation. The model may be applicable wherever mosquitoes are selected from a population/laboratory colony and then compared back to their &#x0201c;parental&#x0201d; group or strain. The function depends on the mortality rate which is given by the number of susceptible individuals in the selection experiment. (B) The graph plots the relationship between observed and &#x0201c;true&#x0201d; ratio for the mortality observed in this study (<italic>m</italic>&#x0200a;&#x0003d;&#x0200a;0.58) and for a 25&#x00025; and 75&#x00025; mortality rate.</p><p>(0.32 MB TIF)</p></caption><media xlink:href="pgen.1000286.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We are grateful to David Weetman, Sam Dadzie and family for field support in Ghana. Margaret Hughes and Andrew Cossins from the Liverpool Microarray Facility helped with the printing of microarray slides. We would also like to thank the members of the LSTM Vector Group for fruitful discussions.</p></ack><ref-list><title>References</title><ref id="pgen.1000286-Pinto1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>J</given-names></name><name><surname>Lynd</surname><given-names>A</given-names></name><name><surname>Vicente</surname><given-names>JL</given-names></name><name><surname>Santolamazza</surname><given-names>F</given-names></name><name><surname>Randle</surname><given-names>NP</given-names></name><etal/></person-group><year>2007</year><article-title>Multiple origins of knockdown resistance mutations in the Afrotropical mosquito vector <italic>Anopheles gambiae</italic>.</article-title><source>PLoS ONE</source><volume>2</volume><fpage>e1243</fpage><pub-id pub-id-type="pmid">18043750</pub-id></citation></ref><ref id="pgen.1000286-WHO1"><label>2</label><citation citation-type="book"><collab>WHO, UNICEF</collab><year>2005</year><source>World Malaria Report</source><publisher-loc>Geneva, Switzerland</publisher-loc><publisher-name>World Health Organization</publisher-name></citation></ref><ref id="pgen.1000286-NGuessan1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>N'Guessan</surname><given-names>R</given-names></name><name><surname>Corbel</surname><given-names>V</given-names></name><name><surname>Akogb&#x000e9;to</surname><given-names>M</given-names></name><name><surname>Rowland</surname><given-names>M</given-names></name></person-group><year>2007</year><article-title>Reduced efficacy of insecticide-treated nets and indoor residual spraying for malaria control in pyrethroid resistance area, Benin.</article-title><source>Emerg Infect Dis</source><volume>13</volume><fpage>199</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">17479880</pub-id></citation></ref><ref id="pgen.1000286-Santolamazza1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santolamazza</surname><given-names>F</given-names></name><name><surname>Calzetta</surname><given-names>M</given-names></name><name><surname>Etang</surname><given-names>J</given-names></name><name><surname>Barrese</surname><given-names>E</given-names></name><name><surname>Dia</surname><given-names>I</given-names></name><etal/></person-group><year>2008</year><article-title>Distribution of knock-down resistance mutations in <italic>Anopheles gambiae</italic> molecular forms in west and west-central Africa.</article-title><source>Malar J</source><volume>7</volume><fpage>74</fpage><pub-id pub-id-type="pmid">18445265</pub-id></citation></ref><ref id="pgen.1000286-Hemingway1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hemingway</surname><given-names>J</given-names></name><name><surname>Ranson</surname><given-names>H</given-names></name></person-group><year>2000</year><article-title>Insecticide resistance in insect vectors of human disease.</article-title><source>Annu Rev Entomol</source><volume>45</volume><fpage>371</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">10761582</pub-id></citation></ref><ref id="pgen.1000286-MartinezTorres1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Torres</surname><given-names>D</given-names></name><name><surname>Chandre</surname><given-names>F</given-names></name><name><surname>Williamson</surname><given-names>MS</given-names></name><name><surname>Darriet</surname><given-names>F</given-names></name><name><surname>Berge</surname><given-names>JB</given-names></name><etal/></person-group><year>1998</year><article-title>Molecular characterization of pyrethroid knockdown resistance (<italic>kdr</italic>) in the major malaria vector <italic>Anopheles gambiae</italic> s.s.</article-title><source>Insect Mol Biol</source><volume>7</volume><fpage>179</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">9535162</pub-id></citation></ref><ref id="pgen.1000286-Ranson1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ranson</surname><given-names>H</given-names></name><name><surname>Jensen</surname><given-names>B</given-names></name><name><surname>Vulule</surname><given-names>JM</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Hemingway</surname><given-names>J</given-names></name><etal/></person-group><year>2000</year><article-title>Identification of a point mutation in the voltage-gated sodium channel gene of Kenyan <italic>Anopheles gambiae</italic> associated with resistance to DDT and pyrethroids.</article-title><source>Insect Mol Biol</source><volume>9</volume><fpage>491</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">11029667</pub-id></citation></ref><ref id="pgen.1000286-Feyereisen1"><label>8</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Feyereisen</surname><given-names>R</given-names></name></person-group><year>2005</year><article-title>Insect cytochrome P450.</article-title><person-group person-group-type="editor"><name><surname>Gilbert</surname><given-names>LI</given-names></name><name><surname>Iatrou</surname><given-names>K</given-names></name><name><surname>Gill</surname><given-names>SS</given-names></name></person-group><source>Comprehensive Molecular Insect Science</source><publisher-name>Elsevier</publisher-name><fpage>1</fpage><lpage>77</lpage></citation></ref><ref id="pgen.1000286-Li1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Schuler</surname><given-names>MA</given-names></name><name><surname>Berenbaum</surname><given-names>MR</given-names></name></person-group><year>2007</year><article-title>Molecular mechanisms of metabolic resistance to synthetic and natural xenobiotics.</article-title><source>Annu Rev Entomol</source><volume>52</volume><fpage>231</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">16925478</pub-id></citation></ref><ref id="pgen.1000286-Ranson2"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ranson</surname><given-names>H</given-names></name><name><surname>Claudianos</surname><given-names>C</given-names></name><name><surname>Ortelli</surname><given-names>F</given-names></name><name><surname>Abgrall</surname><given-names>C</given-names></name><name><surname>Hemingway</surname><given-names>J</given-names></name><etal/></person-group><year>2002</year><article-title>Evolution of supergene families associated with insecticide resistance.</article-title><source>Science</source><volume>298</volume><fpage>179</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">12364796</pub-id></citation></ref><ref id="pgen.1000286-David1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>JP</given-names></name><name><surname>Strode</surname><given-names>C</given-names></name><name><surname>Vontas</surname><given-names>J</given-names></name><name><surname>Nikou</surname><given-names>D</given-names></name><name><surname>Vaughan</surname><given-names>A</given-names></name><etal/></person-group><year>2005</year><article-title>The <italic>Anopheles gambiae</italic> detoxification chip: a highly specific microarray to study metabolic-based insecticide resistance in malaria vectors.</article-title><source>Proc Natl Acad Sci U S A</source><volume>102</volume><fpage>4080</fpage><lpage>4084</lpage><pub-id pub-id-type="pmid">15753317</pub-id></citation></ref><ref id="pgen.1000286-Mller1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>P</given-names></name><name><surname>Donnelly</surname><given-names>MJ</given-names></name><name><surname>Ranson</surname><given-names>H</given-names></name></person-group><year>2007</year><article-title>Transcription profiling of a recently colonised pyrethroid resistant <italic>Anopheles gambiae</italic> strain from Ghana.</article-title><source>BMC Genomics</source><volume>8</volume><fpage>e36</fpage></citation></ref><ref id="pgen.1000286-Nikou1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nikou</surname><given-names>D</given-names></name><name><surname>Ranson</surname><given-names>H</given-names></name><name><surname>Hemingway</surname><given-names>J</given-names></name></person-group><year>2003</year><article-title>An adult-specific CYP6 P450 gene is overexpressed in a pyrethroid-resistant strain of the malaria vector, <italic>Anopheles gambiae</italic>.</article-title><source>Gene</source><volume>318</volume><fpage>91</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">14585502</pub-id></citation></ref><ref id="pgen.1000286-Chiu1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>TL</given-names></name><name><surname>Wen</surname><given-names>Z</given-names></name><name><surname>Rupasinghe</surname><given-names>SG</given-names></name><name><surname>Schuler</surname><given-names>MA</given-names></name></person-group><year>2008</year><article-title>Comparative molecular modelling of <italic>Anopheles gambiae</italic> CYP6Z1, a mosquito P450 capable of metabolizing DDT.</article-title><source>Proc Natl Acad Sci U S A</source><volume>105</volume><fpage>8855</fpage><lpage>8860</lpage><pub-id pub-id-type="pmid">18577597</pub-id></citation></ref><ref id="pgen.1000286-McLaughlin1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McLaughlin</surname><given-names>LA</given-names></name><name><surname>Niazi</surname><given-names>U</given-names></name><name><surname>Bibby</surname><given-names>J</given-names></name><name><surname>David</surname><given-names>JP</given-names></name><name><surname>Vontas</surname><given-names>J</given-names></name><etal/></person-group><year>2008</year><article-title>Characterization of inhibitors and substrates of <italic>Anopheles gambiae</italic> CYP6Z2.</article-title><source>Insect Mol Biol</source><volume>17</volume><fpage>125</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">18353102</pub-id></citation></ref><ref id="pgen.1000286-Riehle1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riehle</surname><given-names>MM</given-names></name><name><surname>Markianos</surname><given-names>K</given-names></name><name><surname>Niare</surname><given-names>O</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><year>2006</year><article-title>Natural malaria infection in <italic>Anopheles gambiae</italic> is regulated by a single genomic control region.</article-title><source>Science</source><volume>312</volume><fpage>577</fpage><lpage>579</lpage><pub-id pub-id-type="pmid">16645095</pub-id></citation></ref><ref id="pgen.1000286-Hemingway2"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hemingway</surname><given-names>J</given-names></name><name><surname>Beaty</surname><given-names>BJ</given-names></name><name><surname>Rowland</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>TW</given-names></name><name><surname>Sharp</surname><given-names>BL</given-names></name></person-group><year>2006</year><article-title>The Innovative Vector Control Consortium: improved control of mosquito-borne diseases.</article-title><source>Trends Parasitol</source><volume>22</volume><fpage>308</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">16713358</pub-id></citation></ref><ref id="pgen.1000286-Yawson1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yawson</surname><given-names>AE</given-names></name><name><surname>McCall</surname><given-names>PJ</given-names></name><name><surname>Wilson</surname><given-names>MD</given-names></name><name><surname>Donnelly</surname><given-names>MJ</given-names></name></person-group><year>2004</year><article-title>Species abundance and insecticide resistance of <italic>Anopheles gambiae</italic> in selected areas of Ghana and Burkina Faso.</article-title><source>Med Vet Entomol</source><volume>18</volume><fpage>372</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">15642004</pub-id></citation></ref><ref id="pgen.1000286-Gillies1"><label>19</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Gillies</surname><given-names>MT</given-names></name><name><surname>De Meillon</surname><given-names>B</given-names></name></person-group><year>1968</year><source>The Anophelinae of Africa south of the Sahara</source><publisher-loc>Johannesburg, South Africa</publisher-loc><publisher-name>South African Institute of Medical Research</publisher-name><fpage>343</fpage></citation></ref><ref id="pgen.1000286-Gillies2"><label>20</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Gillies</surname><given-names>MT</given-names></name><name><surname>Coetzee</surname><given-names>M</given-names></name></person-group><year>1987</year><source>A supplement to the Anophelinae of Africa south of the Sahara</source><publisher-loc>Johannesburg, South Africa</publisher-loc><publisher-name>South African Institute of Medical Research</publisher-name><fpage>143</fpage></citation></ref><ref id="pgen.1000286-Mller2"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>P</given-names></name><name><surname>Chouaibou</surname><given-names>M</given-names></name><name><surname>Pignatelli</surname><given-names>P</given-names></name><name><surname>Etang</surname><given-names>J</given-names></name><name><surname>Walker</surname><given-names>ED</given-names></name><etal/></person-group><year>2008</year><article-title>Pyrethroid tolerance is associated with elevated expression of antioxidants and agricultural practice in <italic>Anopheles arabiensis</italic> sampled from an area of cotton fields in Northern Cameroon.</article-title><source>Mol Ecol</source><volume>17</volume><fpage>1145</fpage><lpage>1155</lpage><pub-id pub-id-type="pmid">18179425</pub-id></citation></ref><ref id="pgen.1000286-WHO2"><label>22</label><citation citation-type="book"><collab>WHO</collab><year>1998</year><source>Tests Procedures for Insecticide Resistance Monitoring in Malaria Vectors, Bio-Efficacy and Persistence of Insecticides on Treated Surfaces</source><publisher-loc>Geneva, Switzerland</publisher-loc><publisher-name>WHO</publisher-name></citation></ref><ref id="pgen.1000286-Pampel1"><label>23</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Pampel</surname><given-names>FC</given-names></name></person-group><year>2000</year><article-title>Logistic Regression: A Primer;</article-title><person-group person-group-type="editor"><name><surname>Lewis-Beck</surname><given-names>MS</given-names></name></person-group><publisher-loc>California</publisher-loc><publisher-name>Sage</publisher-name><fpage>96</fpage></citation></ref><ref id="pgen.1000286-Vontas1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vontas</surname><given-names>J</given-names></name><name><surname>Blass</surname><given-names>C</given-names></name><name><surname>Koutsos</surname><given-names>AC</given-names></name><name><surname>David</surname><given-names>JP</given-names></name><name><surname>Kafatos</surname><given-names>FC</given-names></name><etal/></person-group><year>2005</year><article-title>Gene expression in insecticide resistant and susceptible <italic>Anopheles gambiae</italic> strains constitutively or after insecticide exposure.</article-title><source>Insect Mol Biol</source><volume>14</volume><fpage>509</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">16164607</pub-id></citation></ref><ref id="pgen.1000286-Fanello1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fanello</surname><given-names>C</given-names></name><name><surname>Santolamazza</surname><given-names>F</given-names></name><name><surname>della Torre</surname><given-names>A</given-names></name></person-group><year>2002</year><article-title>Simultaneous identification of species and molecular forms of the <italic>Anopheles gambiae</italic> complex by PCR-RFLP.</article-title><source>Med Vet Entomol</source><volume>16</volume><fpage>461</fpage><lpage>464</lpage><pub-id pub-id-type="pmid">12510902</pub-id></citation></ref><ref id="pgen.1000286-Lynd1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lynd</surname><given-names>A</given-names></name><name><surname>Ranson</surname><given-names>H</given-names></name><name><surname>McCall</surname><given-names>PJ</given-names></name><name><surname>Randle</surname><given-names>NP</given-names></name><name><surname>Black</surname><given-names>WC</given-names><suffix>IV</suffix></name><etal/></person-group><year>2005</year><article-title>A simplified high-throughput method for pyrethroid knock-down resistance (<italic>kdr</italic>) detection in <italic>Anopheles gambiae</italic>.</article-title><source>Malar J</source><volume>4</volume><fpage>16</fpage><pub-id pub-id-type="pmid">15766386</pub-id></citation></ref><ref id="pgen.1000286-Smyth1"><label>27</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><year>2005</year><article-title>Limma: linear models for microarray data.</article-title><person-group person-group-type="editor"><name><surname>Gentleman</surname><given-names>R</given-names></name><name><surname>Carey</surname><given-names>V</given-names></name><name><surname>Dudoit</surname><given-names>S</given-names></name><name><surname>Irizarry</surname><given-names>R</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><source>Bioinformatics and Computational Biology Solutions using R and Bioconductor</source><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name><fpage>397</fpage><lpage>420</lpage></citation></ref><ref id="pgen.1000286-Barnes1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>HJ</given-names></name><name><surname>Arlotto</surname><given-names>MP</given-names></name><name><surname>Waterman</surname><given-names>MR</given-names></name></person-group><year>1991</year><article-title>Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in <italic>Escherichia coli</italic>.</article-title><source>Proc Natl Acad Sci U S A</source><volume>88</volume><fpage>5597</fpage><lpage>5601</lpage><pub-id pub-id-type="pmid">1829523</pub-id></citation></ref><ref id="pgen.1000286-Omura1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Omura</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>R</given-names></name></person-group><year>1964</year><article-title>The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature.</article-title><source>J Biol Chem</source><volume>239</volume><fpage>2370</fpage><lpage>2378</lpage><pub-id pub-id-type="pmid">14209971</pub-id></citation></ref><ref id="pgen.1000286-Pritchard1"><label>30</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Pritchard</surname><given-names>M</given-names></name><name><surname>McLaughlin</surname><given-names>LA</given-names></name><name><surname>Friedberg</surname><given-names>T</given-names></name></person-group><year>2006</year><article-title>Establishment of functional human cytochrome P450 monooxygenase systems in <italic>Escherichia coli</italic>.</article-title><person-group person-group-type="editor"><name><surname>Philips</surname><given-names>IR</given-names></name><name><surname>Shephard</surname><given-names>EA</given-names></name></person-group><source>Methods in Molecular Biology: Cytochrome P450 Protocols: Second Edition</source><publisher-loc>Totowa, NJ</publisher-loc><publisher-name>Humana Press Inc</publisher-name><fpage>19</fpage><lpage>29</lpage></citation></ref><ref id="pgen.1000286-Morey1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morey</surname><given-names>JS</given-names></name><name><surname>Ryan</surname><given-names>JC</given-names></name><name><surname>Van Dolah</surname><given-names>FM</given-names></name></person-group><year>2006</year><article-title>Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR.</article-title><source>Biol Proced Online</source><volume>8</volume><fpage>175</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">17242735</pub-id></citation></ref><ref id="pgen.1000286-Reimer1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reimer</surname><given-names>L</given-names></name><name><surname>Fondjo</surname><given-names>E</given-names></name><name><surname>Patchoke</surname><given-names>S</given-names></name><name><surname>Diallo</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><etal/></person-group><year>2008</year><article-title>Relationship between <italic>kdr</italic> mutation and resistance to pyrethroid and DDT insecticides in natural populations of <italic>Anopheles gambiae</italic>.</article-title><source>J Med Entomol</source><volume>45</volume><fpage>260</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">18402142</pub-id></citation></ref><ref id="pgen.1000286-Peleg1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peleg</surname><given-names>M</given-names></name><name><surname>Normand</surname><given-names>M</given-names></name><name><surname>Damrau</surname><given-names>E</given-names></name></person-group><year>1997</year><article-title>Mathematical interpretation of dose-response curves.</article-title><source>Bull Math Biol</source><volume>59</volume><fpage>747</fpage><lpage>761</lpage></citation></ref><ref id="pgen.1000286-Amenya1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amenya</surname><given-names>DA</given-names></name><name><surname>Koekemoer</surname><given-names>LL</given-names></name><name><surname>Vaughan</surname><given-names>A</given-names></name><name><surname>Morgan</surname><given-names>JC</given-names></name><name><surname>Brooke</surname><given-names>BD</given-names></name><etal/></person-group><year>2005</year><article-title>Isolation and sequence analysis of P450 genes from a pyrethroid resistant colony of the major malaria vector <italic>Anopheles funestus</italic>.</article-title><source>DNA Seq</source><volume>16</volume><fpage>437</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">16287623</pub-id></citation></ref><ref id="pgen.1000286-Wondji1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wondji</surname><given-names>C</given-names></name><name><surname>Morgan</surname><given-names>J</given-names></name><name><surname>Coetzee</surname><given-names>M</given-names></name><name><surname>Hunt</surname><given-names>RH</given-names></name><name><surname>Steen</surname><given-names>K</given-names></name><etal/></person-group><year>2007</year><article-title>Mapping a Quantitative Trait Loci (QTL) conferring pyrethroid resistance in the African malaria vector <italic>Anopheles funestus</italic>.</article-title><source>BMC Genomics</source><volume>8</volume><fpage>e34</fpage></citation></ref><ref id="pgen.1000286-Amenya2"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amenya</surname><given-names>DA</given-names></name><name><surname>Naguran</surname><given-names>R</given-names></name><name><surname>Lo</surname><given-names>TC</given-names></name><name><surname>Ranson</surname><given-names>H</given-names></name><name><surname>Spillings</surname><given-names>BL</given-names></name><etal/></person-group><year>2008</year><article-title>Over expression of a cytochrome P450 (<italic>CYP6P9</italic>) in a major African malaria vector, <italic>Anopheles funestus</italic>, resistant to pyrethroids.</article-title><source>Insect Mol Biol</source><volume>17</volume><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">18237281</pub-id></citation></ref><ref id="pgen.1000286-Shono1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shono</surname><given-names>T</given-names></name><name><surname>Unai</surname><given-names>T</given-names></name><name><surname>Casida</surname><given-names>JE</given-names></name></person-group><year>1978</year><article-title>Metabolism of permethrin isomers in American cockroach adults, house fly adults, and cabbage looper larvae.</article-title><source>Pestic Biochem Physiol</source><volume>9</volume><fpage>96</fpage><lpage>106</lpage></citation></ref><ref id="pgen.1000286-Li2"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Baudry</surname><given-names>J</given-names></name><name><surname>Berenbaum</surname><given-names>MR</given-names></name><name><surname>Schuler</surname><given-names>MA</given-names></name></person-group><year>2004</year><article-title>Structural and functional divergence of insect CYP6B proteins: from specialist to generalist cytochrome P450.</article-title><source>Proc Natl Acad Sci U S A</source><volume>101</volume><fpage>2939</fpage><lpage>2944</lpage><pub-id pub-id-type="pmid">14981232</pub-id></citation></ref><ref id="pgen.1000286-Godin1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Godin</surname><given-names>SJ</given-names></name><name><surname>Crow</surname><given-names>JA</given-names></name><name><surname>Scollon</surname><given-names>EJ</given-names></name><name><surname>Hughes</surname><given-names>MF</given-names></name><name><surname>DeVito</surname><given-names>MJ</given-names></name><etal/></person-group><year>2007</year><article-title>Identification of rat and human cytochrome p450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides deltamethrin and esfenvalerate.</article-title><source>Drug Metab Dispos</source><volume>35</volume><fpage>1664</fpage><lpage>1671</lpage><pub-id pub-id-type="pmid">17576809</pub-id></citation></ref><ref id="pgen.1000286-Zhang1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>JG</given-names></name></person-group><year>1996</year><article-title>Cytochrome b5 is essential for cytochrome P450 6D1-mediated cypermethrin resistance in LPR house flies.</article-title><source>Pestic Biochem Physiol</source><volume>55</volume><fpage>150</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">8980039</pub-id></citation></ref><ref id="pgen.1000286-Benjamini1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname><given-names>Y</given-names></name><name><surname>Hochberg</surname><given-names>Y</given-names></name></person-group><year>1995</year><article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing.</article-title><source>J Roy Stat Soc B</source><volume>57</volume><fpage>289</fpage><lpage>300</lpage></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p>The study was funded by the Innovative Vector Control Consortium.</p></fn></fn-group></back></article> 